BlackRock Institutional Trust’s Evolent Health EVH Stock Holding History

BlackRock Institutional Trust’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.55M	Buy	442,412 +121,055	+38%	+$2.39M	﹤0.01%	2626
2016 Q3	$7.91M	Buy	321,357 +3,519	+1%	+$82.3K	﹤0.01%	2480
2016 Q2	$6.1M	Buy	317,838 +66,773	+27%	+$917K	﹤0.01%	2577
2016 Q1	$2.65M	Sell	251,065 -2,517	-1%	-$26K	﹤0.01%	2928
2015 Q4	$3.07M	Buy	253,582 +37,800	+18%	+$557K	﹤0.01%	2931
2015 Q3	$3.44M	Buy	215,782 +201,591	+1,421%	+$3.93M	﹤0.01%	2889
2015 Q2	$277K	Buy	+14,191	New	+$265K	﹤0.01%	3595

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlackRock Institutional Trust's EVH Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Evolent Health (EVH) stake by 38% in Q4 2016, buying an estimated $2.39M and bringing the position to 442,412 shares worth $6.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

BlackRock Institutional Trust first reported a position in EVH in Q2 2015 and has held it in 7 quarters since. The position peaked at $7.91M in Q3 2016. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

BlackRock Institutional Trust held 442,412 shares of Evolent Health worth $6.55M as of Q4 2016.
BlackRock Institutional Trust bought 121,055 Evolent Health shares in Q4 2016, an estimated $2.39M.
Evolent Health made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2626 holding.
BlackRock Institutional Trust first reported a position in Evolent Health in Q2 2015 and has held it in 7 quarters since.
BlackRock Institutional Trust's Evolent Health position peaked at $7.91M in Q3 2016.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.